Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
Curti, B. D., Koguchi, Y., Leidner, R. S., Rolig, A. S., Sturgill, E. R., Sun, Z., Wu, Y., Rajamanickam, V., Bernard, B., Hilgart-Martiszus, I., Fountain, C. B., Morris, G., Iwamoto, N., Shimada, T., Chang, S., Traber, P. G., Zomer, E., Horton, J. R., Shlevin, H., & Redmond, W. L. (2021). Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor. Journal for immunotherapy of cancer, 9(4), e002371. https://doi.org/10.1136/jitc-2021-002371